kentucky semaglutide nausea lawsuit Ozempic Stomach Paralysis Led to Hospitalization for Severe Vomiting, Abdominal Pain: semaglutide nausea class action in

A phase III clinical trial showed that the incidence of headache and facial flushing in the spray group was 20% lower than that in the tablet group, and the incidence of muscle pain was 15% lower

Disease modification in Parkinsons disease: current approaches, challenges, and future considerations

Key Cardiovascular Findings: Up to 18% reduction in serious cardiovascular events (heart attacks, strokes) Protection occurs regardless of weight loss amount Improved blood vessel function and reduced inflammation Benefits seen within 3-6 months of treatment initiation Reduced cardiovascular death risk As The Times of India reported (November 16, 2025): New research indicates Ozempic and Mounjaro offer significant cardiovascular benefits beyond weight loss and blood sugar control. Critical New Research: What Happens When You Stop

Important safety information: Mounjaro (tirzepatide) is a prescription-only medication for treating type 2 diabetes and managing obesity

Adequate protein intake and slower titration can minimize this risk